Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A timely warning: Clock drawing errors in young adults and the long-term validity of cognitive screens.

The Clinical neuropsychologist·2026
Same author

Liver Conditions Specific to Pregnancy: Optimizing Management and Outcomes.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
Same author

EASL position paper on palliative care in advanced chronic liver disease.

JHEP reports : innovation in hepatology·2026
Same author

Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future.

JHEP reports : innovation in hepatology·2026
Same author

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Nature reviews. Gastroenterology & hepatology·2026
Same author

Neural responses to acute hypoxia and hyperoxia.

Neuroscience·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: May 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

自己免疫性肝炎は,自己免疫性肝炎によって引き起こされる.

Michael A Heneghan1, Andrew D Yeoman, Sumita Verma

  • 1Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK.

Lancet (London, England)
|June 18, 2013
PubMed
まとめ
この要約は機械生成です。

免疫媒介性肝疾患である自己免疫性肝炎は,ほとんどの場合,効果的に治療できます. 肝臓移植のような先進的な治療法は,重症または末期肝疾患に対する解決策を提供します.

さらに関連する動画

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

関連する実験動画

Last Updated: May 10, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

科学分野:

  • 肝臓病理学 肝臓病理学
  • 免疫学 免疫学とは
  • 内科内科は,内科の内科である.

背景:

  • 自己免疫性肝炎 (AIH) は,急性および慢性的な症状を持つ肝臓パレンキマ疾患です.
  • AIHは,臓器特異でない抗体や肝臓の自己免疫を含む,他の自己免疫疾患と特徴を共有し,その病理生理学を複雑にします.
  • 最近の研究では,AIHの病原性における規制性T細胞の役割が強調されています.

研究 の 目的:

  • 自己免疫性肝炎に関する現在の理解を要約すると,
  • 診断上の課題と治療戦略について議論する.
  • 変異性シンドロームを考慮する重要性を強調するために.

主な方法:

  • 自己免疫性肝炎に関する最新の科学文献のレビュー.
  • 病気のトリガーと遺伝的感受性に関するデータの分析.
  • 治療結果と移植の有効性の評価.

主要な成果:

  • 患者の最大85%は,現在の治療法で臨床的および生化学的寛解を達成します.
  • 応答しない患者には,代替の免疫抑制戦略が利用できます.
  • 肝臓移植は,急性肝不全および肝細胞癌のような末期疾患合併症に非常に効果的です.

結論:

  • 自己免疫性肝炎は,高い寛解率を持つ管理可能な状態です.
  • 遺伝的易感性と環境的トリガーは,疾患の発症に役割を果たします.
  • 肝臓移植は,病気が進行した段階で重要な選択肢です.